We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
-14.29%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$16.5B
AUM Growth
-$3.93B
Cap. Flow
-$718M
Cap. Flow %
-4.36%
Top 10 Hldgs %
32.53%
Holding
1,265
New
250
Increased
403
Reduced
360
Closed
243

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$87M
2
QSR icon
Restaurant Brands International
QSR
+$63.5M
3
BIP icon
Brookfield Infrastructure Partners
BIP
+$62.1M
4
AZN icon
AstraZeneca
AZN
+$55.4M
5
AQN icon
Algonquin Power & Utilities
AQN
+$54.6M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$159M
2
RY icon
Royal Bank of Canada
RY
+$100M
3
VRN
Veren
VRN
+$89.9M
4
WPM icon
Wheaton Precious Metals
WPM
+$88.9M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$78.3M

Sector Composition

Rank Sector Weight
1 Financials 27.58%
2 Energy 14.56%
3 Industrials 13.17%
4 Technology 10.16%
5 Materials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SXC icon
901
SunCoke Energy
SXC
$783M
$245K ﹤0.01%
+35,938
New +$290K
NSTG
902
DELISTED
NanoString Technologies, Inc.
NSTG
$244K ﹤0.01%
+19,190
New +$357K
CMS icon
903
CMS Energy
CMS
$22.1B
$243K ﹤0.01%
+3,597
New +$248K
ATLO icon
904
AMES National
ATLO
$283M
$241K ﹤0.01%
10,885
-4,231
-28% -$98.5K
CNNE icon
905
Cannae Holdings
CNNE
$675M
$238K ﹤0.01%
+12,327
New +$259K
EVBN
906
DELISTED
Evans Bancorp Inc
EVBN
$238K ﹤0.01%
7,009
-327
-4% -$12.1K
RVMD icon
907
Revolution Medicines
RVMD
$43.3B
$235K ﹤0.01%
+12,033
New +$234K
BLKB icon
908
Blackbaud
BLKB
$2.11B
$231K ﹤0.01%
+3,976
New +$231K
FF icon
909
Future Fuel
FF
$252M
$227K ﹤0.01%
31,145
-35,708
-53% -$300K
STOK icon
910
Stoke Therapeutics
STOK
$2.04B
$227K ﹤0.01%
17,161
+5,204
+44% +$79.1K
LGIH icon
911
LGI Homes
LGIH
$1.36B
$224K ﹤0.01%
+2,576
New +$239K
PBYI icon
912
Puma Biotechnology
PBYI
$449M
$221K ﹤0.01%
77,591
-13,140
-14% -$32.7K
ADEA icon
913
Adeia
ADEA
$3.15B
$220K ﹤0.01%
+57,539
New +$241K
SVRA icon
914
Savara
SVRA
$1.09B
$220K ﹤0.01%
144,432
+9,363
+7% +$12.3K
TDW icon
915
Tidewater
TDW
$4.54B
$219K ﹤0.01%
10,406
-6,466
-38% -$149K
KOD icon
916
Kodiak Sciences
KOD
$2.53B
$216K ﹤0.01%
28,306
+15,267
+117% +$107K
TRHC
917
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$216K ﹤0.01%
83,927
+744
+0.9% +$2.79K
REXR icon
918
Rexford Industrial Realty
REXR
$8.14B
$215K ﹤0.01%
+3,735
New +$257K
HSIC icon
919
Henry Schein
HSIC
$10B
$214K ﹤0.01%
+2,794
New +$234K
LCTX icon
920
Lineage Cell Therapeutics
LCTX
$268M
$214K ﹤0.01%
135,328
+123,328
+1,028% +$163K
RLX icon
921
RLX Technology
RLX
$2.44B
$214K ﹤0.01%
100,578
+3,305
+3% +$6.65K
RMD icon
922
ResMed
RMD
$32.9B
$214K ﹤0.01%
1,023
-662
-39% -$141K
XNET
923
Xunlei
XNET
$329M
$213K ﹤0.01%
134,763
+49,524
+58% +$70.4K
ATEX icon
924
Anterix
ATEX
$1.79B
$212K ﹤0.01%
5,169
-435
-8% -$21.1K
EC icon
925
Ecopetrol
EC
$35.3B
$212K ﹤0.01%
+19,511
New +$310K
35 36
37
38 39

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q2 2022 Portfolio in Review

As of Q2 2022, Connor, Clark & Lunn Investment Management (CC&L) held 1,265 positions worth $16.5B, down 19% from $20.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) withdrew a net $718M in Q2 2022, closing 243 positions and reducing 360 holdings. Its most notable exit was Alibaba, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Connor, Clark & Lunn Investment Management (CC&L) opened a new position in GSK worth $49.3M.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q2 2022 buy was GSK: 905,598 shares worth $49.3M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Canadian National Railway in Q2 2022, an estimated $87M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q2 2022 reduction was Apple, cutting an estimated $159M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Alibaba in Q2 2022, selling an estimated $44.8M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 33% of its $16.5B portfolio in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 250 new positions and closed 243 in Q2 2022.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value fell 19% quarter-over-quarter to $16.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2022, filed 5 Aug 2022.